The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study)-Reference-Cited by-同舟云学术

The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study)

Published:2016-05 Issue: Volume:114 Page:84-90
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Singh Dave,Schröder-Babo Winfried,Cohuet Géraldine,Muraro Annamaria,Bonnet-Gonod Françoise,Petruzzelli Stefano,Hoffmann Martin,Siergiejko Zenon

Funder

Chiesi Farmaceutici S.p.A

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference19 articles.

1. Global Initiative for Chronic Obstructive Lung Disease, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease,2015

2. A 4-year trial of tiotropium in chronic obstructive pulmonary disease;Tashkin;N. Engl. J. Med.,2008

3. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease;Calverley;N. Engl. J. Med.,2007

4. Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations;Wedzicha;Respir. Med.,2014

5. Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPD;Singh;BMC Pulm. Med.,2014

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the pharmacokinetics of beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide delivered via pressurised metered-dose inhaler using a low global warming potential propellant;Pulmonary Pharmacology & Therapeutics;2024-06

2. Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data;Respiratory Research;2024-01-18

3. Breath-taking compliance: Does lower adherence translate to inferiority?;The Journal of Allergy and Clinical Immunology: In Practice;2023-12

4. Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study;International Journal of Chronic Obstructive Pulmonary Disease;2022-12

5. Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution;Therapeutic Advances in Respiratory Disease;2022-01